Table 1. Mutations and deletions of SUZ12 in patients with myeloproliferative neoplasms.

	SUZ12 mutation	SUZ12 loss	ASXL1 mutation	ASXL1 loss	DNMT3A mutation	IDH1/2 mutation	JAK2 mutation	MPL mutation	TET2 mutation	TET2 loss
Polycythemia vera	1/33	0/7	3/33	0/7	1/33	0/33	32/33	0/33	4/33	0/7
Essential thrombocythemia	0/51	0/19	2/51	0/19	0/51	0/51	32/51	0/51	3/51	0/19
Myelofibrosis	0/35	1/35	8/35	1/35	1/35	0/35	24/35	0/35	4/35	0/35
Other MPN	0/6	0/6	2/6	0/6	0/6	0/6	1/6	0/6	2/6	0/6
Blast phase MPN	1/14a	2/13a	2/14	0/13	0/14	2/14	4/14	1/14	2/14a	2/13a
Total MPNs	2/139a	3/80a	17/139	1/80	2/139	2/139	93/139	1/139	15/139a	2/80a

Abbreviation: MPN, myeloproliferative neoplasm.

^aHD-1038 sample in common.